AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.91 Million | 1.3 Million | 418.23 Thousand | 732.7 Thousand | 412.85 Thousand | 470.69 Thousand |
| Net Income | -14.16 Thousand | 626.33 Thousand | 880.9 Thousand | 274.61 Thousand | 165.09 Thousand | 34.62 Thousand |
| Depreciation & Amortization | 551.31 Thousand | 427.88 Thousand | 286.64 Thousand | 234.82 Thousand | 196.88 Thousand | 151.43 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.36 Million | 248.88 Thousand | -748.24 Thousand | 223.25 Thousand | 50.87 Thousand | 284.35 Thousand |
| Other non-cash items | 12.03 Thousand | 4837.00 | -1064.00 | 247.46 Thousand | 343.82 Thousand | 276.00 |
| Investing Cash Flow | -2.47 Million | -843.77 Thousand | -1.11 Million | -515.11 Thousand | -189.48 Thousand | 173.2 Thousand |
| Investments in PPE | -2.47 Million | -843.77 Thousand | -1.11 Million | -515.11 Thousand | -190.16 Thousand | -86.45 Thousand |
| Acquisitions | - | - | - | - | 680.00 | 69.66 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 190 Thousand |
| Financing Cash Flow | -80 Thousand | -160 Thousand | -56 Thousand | -440 Thousand | -80 Thousand | -320 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -80 Thousand | -160 Thousand | -56 Thousand | -440 Thousand | -80 Thousand | -320 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 614.48 Thousand | 164.53 Thousand | -817.87 Thousand | 13.03 Thousand | 96.92 Thousand | -97.02 Thousand |
| Accounts payables | 767.85 Thousand | -65.41 Thousand | 87.59 Thousand | 247.03 Thousand | -61.84 Thousand | 596.01 Thousand |
| Inventory | -18.3 Thousand | 13.31 Thousand | -17.96 Thousand | -36.81 Thousand | 15.79 Thousand | 2852.00 |
| Other working capital | 767.85 Thousand | 136.44 Thousand | - | - | - | 281.5 Thousand |
| Cash at beginning of period | 1.32 Million | 1.01 Million | 1.76 Million | 1.98 Million | 1.84 Million | 1.39 Million |
| Cash at end of period | 674.79 Thousand | 1.32 Million | 1.01 Million | 1.76 Million | 1.98 Million | 1.84 Million |
| Capital Expenditure | -2.47 Million | -843.77 Thousand | -1.11 Million | -515.11 Thousand | -190.16 Thousand | -86.45 Thousand |
| Effect of forex changes on cash | 119.00 | - | - | - | - | 128.88 Thousand |
| Net cash flow / Change in cash | -646.3 Thousand | 304.16 Thousand | -747.78 Thousand | -222.41 Thousand | 143.37 Thousand | 452.78 Thousand |
| Free Cash Flow | -566.42 Thousand | 464.16 Thousand | -691.78 Thousand | 217.58 Thousand | 222.69 Thousand | 384.23 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -119.75 Thousand | 91.32 Thousand | -14.16 Thousand | -98.64 Thousand | 284.38 Thousand | -65.23 Thousand |
| Depreciation & Amortization | 153 Thousand | 149.5 Thousand | 551.31 Thousand | 162.43 Thousand | 148.41 Thousand | 121.66 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 75.5 Thousand | -190.04 Thousand | 1.36 Million | -135.2 Thousand | -183.99 Thousand | 1.76 Million |
| Other non-cash items | 230.49 Thousand | 489.05 Thousand | 12.03 Thousand | 1.00 | 12.06 Thousand | -30.00 |
| Investing Cash Flow | -219.01 Thousand | -29.85 Thousand | -2.47 Million | -39.26 Thousand | -1861.00 | -1.86 Million |
| Investments in PPE | -219.01 Thousand | -29.85 Thousand | -2.47 Million | -39.26 Thousand | -1861.00 | -1.86 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -80 Thousand | -80 Thousand | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -80 Thousand | -80 Thousand | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 62.82 Thousand | -37.74 Thousand | 614.48 Thousand | 74.3 Thousand | -58.35 Thousand | 610.34 Thousand |
| Accounts payables | 42.28 Thousand | -137.32 Thousand | 767.85 Thousand | -211.46 Thousand | -120.86 Thousand | 1.16 Million |
| Inventory | -29.59 Thousand | -14.96 Thousand | -18.3 Thousand | 1958.00 | -4783.00 | -10.89 Thousand |
| Other working capital | 42.28 Thousand | - | - | - | - | - |
| Cash at beginning of period | 695.73 Thousand | 674.79 Thousand | 1.32 Million | 865.66 Thousand | 606.66 Thousand | 644.23 Thousand |
| Cash at end of period | 585.47 Thousand | 695.73 Thousand | 674.79 Thousand | 674.79 Thousand | 865.66 Thousand | 606.66 Thousand |
| Capital Expenditure | -219.01 Thousand | -29.85 Thousand | -2.47 Million | -39.26 Thousand | -1861.00 | -1.86 Million |
| Effect of forex changes on cash | - | - | 119.00 | -200.00 | - | - |
| Net cash flow / Change in cash | -110.26 Thousand | 20.94 Thousand | -646.3 Thousand | -190.87 Thousand | 259 Thousand | -37.57 Thousand |
| Free Cash Flow | -110.26 Thousand | 20.94 Thousand | -566.42 Thousand | -110.67 Thousand | 259 Thousand | -37.57 Thousand |
LGP
ORA
ABQQ
POBS
ZVRA
VIPCLOTHNG